Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases

Urology

Volumn 50, Issue 2, 1997, Pages 245-250

  Thiounn, Nicolas ^a   Saporta, François ^b   Flam, Thierry A ^b   Pages, Franck ^b   Zerbib, Marc ^b   Vieillefond, Annick ^b   Martin, Emmanuel ^b   Debré, Bernard ^b   Chevillard, Sylvie ^b  

^a Hôpital Cochin ^*  (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CELL; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030789262     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00272-0     Document Type: Article

References (34)

1. Parker SL, Tong T, Bolden S, and Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 65: 5-27, 1996.
2. Paulson DF, Moul JW, and Walther PJ: Radical prostatectomy for clinical stage T1-2NOMO prostatic adenocarcinoma: long term results. J Urol 144: 1180-1184, 1990.
3. Walsh PC, Partin AW, and Epstein JI: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152(Suppl 2): 1831-1836, 1994.
4. Voges GE, McNeal JE, Redwine EA, Freiha FS, and Stamey TA: Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 69: 520-526, 1992.
5. Hamdy FC, Lawry J, Anderson JB, Parsons MA, Rees RC, and Williams JL: Circulating prostate specific antigen-positive cells correlate with metastic prostate cancer. Br J Urol 69: 392-396, 1992.
6. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG, and Gomella LG: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 25: 6110-6112, 1992.
7. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, and Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475-482, 1994.
8. Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, and Rovera G: Minimal residual disease in childhood B-lineage lymphoblastic leukemia: persistence of leukemic cells during the first 18 months of treatment. N Engl J Med 323: 448-455, 1990.
9. Mattano LA Jr, Moss TJ, and Emerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701-4705, 1992.
10. Vormwald-Dogan V, Nickel P, Willemse M, Thome M, and Tilgen W: Prevalence of melanoma cells in peripheral blood of patients with malignant-melanoma stage I-IV - detection by polymerase chain reaction. J Clin Dermatol 103: 405-409, 1994.
11. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, et al: The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331: 294-299, 1994.
12. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, Fujihiro S, Kawamura T, Komeda H, Horie M, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 53: 5350-5354, 1993.
13. Israeli RS, Miller WH, Su SL, Powell T, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, et al: Sensitive nested reverse transcription-polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306-6310, 1994.
14. Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, and Buttyan R: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43: 765-775, 1994.
15. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al: Detection of circulating tumor cells in men with localised prostate cancer. J Clin Oncol 12: 2634-2639, 1994.
16. Jaakkola S, Vornamen T, Leinomen J, Rannikko S, and Stenman UH: Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem 41: 182-186, 1995.
17. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF, and Rosai J: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 13: 1195-2000, 1995.
18. Katz AE, de Vries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, Buttyan R, Benson MC, and Olsson CA: Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 75: 1642-1647, 1995.
19. Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O'Toole K, McMahon D, Benson MC, and Katz AE: Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J Urol 153: 1373-1378, 1995.
20. Olsson CA, de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE, and Katz AE: Preoperative reverse transcriptase-polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J Urol 155: 1557-1562, 1996.
21. Sokoloff MH, Tso CL, Kaboo R, Nelson S, Ko J, Dorey F, Figlin RA, Pang S, deKernion J, and Belldegrun A: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol 156: 1560-1566, 1996.
22. Riegman PH, Klaassen P, van der Korput JA, Romijn JC, and Trapman J: Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem Biophys Res Commun 155: 181-188, 1988.
23. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, and Oesterling JE: Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45: 729-744, 1995.
24. Clements J, and Mukhtar A: Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 78: 1536-1539, 1994.
25. Yu H, Diamantis EP, Monne M, and Croce CM: Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem 270: 6615-6618, 1995.
26. Yu H, and Diamantis EP: Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem 41: 204-210, 1995.
27. Yu H, and Diamantis EP: Prostate-specific antigen in milk of lactating women. Clin Chem 41: 54-58, 1995.
28. Diamantis EP, and Yu H: New biological functions of prostate-specific antigen? J Clin Endocrinol Metab 80: 1515-1517, 1995.
29. Levesque M, Yu H, D'Costa M, and Diamantis EP: Prostate-specific antigen expression by various tumors. J Clin Lab Anal 9: 123-128, 1995.
30. Chevillard S, Pouillart P, Beldjord C, Asselain B, Beuzeboc P, Magdelenat H, and Vielh P: Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemeotherapy. Cancer 77: 292-300, 1996.
31. Henke W, Jung M, Jung K, Lein M, Schlechte H, Berndt C, Rudolph B, Schnorr D, and Loening SA: Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cells. Clin Chem 42: 1499-1500, 1996.
32. O'Hara SM, Veltri RW, Skipstunas P, Hedican SP, Partin AW, Nelson JB, Subong ENP, and Walsh PC: Basal PSA mRNA levels detected by quantitative reverse transcriptase-polymerase chain reaction (Q-RT-PCR-PSA) in blood from subjects without prostate cancer (abstract). J Urol 155(suppl): 418A, 1996.
33. Smith MR, Biggar S, and Hussain M: Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implication for detection of micrometastases. Cancer Res 55: 2640-2644, 1995.
34. Troyer JK, Beckett ML, and Wright GL: Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 62: 552-558, 1995.